Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, PR China.
J Proteome Res. 2011 Apr 1;10(4):1953-61. doi: 10.1021/pr101198q. Epub 2011 Feb 22.
A metabonomic approach based on complementary hydrophilic interaction chromatography and reversed-phase liquid chromatography combined with tandem mass spectrometry and time-course analysis of metabolites was implemented to find more reliable potential biomarkers in urine of Walker 256 tumor-bearing rats. A major challenge in metabonomics is distinguishing reliable biomarkers that are closely associated with the genesis and progression of diseases from those that are unrelated but altered significantly. In this study, these biomarkers were selected according to the change trends of discriminating metabolites during the genesis and progression of cancer. Seven consecutive batches of urine samples from preinoculation to 16 days after were collected and analyzed. Multivariate analysis revealed 87 discriminating metabolites. Time-course analysis of discriminating metabolites was used to select more reliable biomarkers with regular and reasonable change trends. Finally, 47 were found and 15 were identified including 12 carnitine derivatives, 2 amino acid derivatives, 1 nucleoside. On the basis of time-course behaviors of these potential biomarkers, we hypothesize such disruption might result from elevated cell proliferation, reduced β-oxidation of fatty acids, and poor renal tubular reabsorption. These studies demonstrate that this method can help to find more reliable potential biomarkers and provide valuable biochemical insights into metabolic alterations in tumor-bearing biosystems.
基于互补亲水作用色谱和反相液相色谱与串联质谱和代谢物时间进程分析相结合的代谢组学方法,旨在寻找 Walker 256 荷瘤大鼠尿液中更可靠的潜在生物标志物。代谢组学的一个主要挑战是区分与疾病的发生和进展密切相关的可靠生物标志物与那些无关但显著改变的生物标志物。在这项研究中,这些生物标志物是根据癌症发生和进展过程中区分代谢物的变化趋势选择的。从接种前到接种后 16 天,共收集并分析了 7 批连续的尿液样本。多变量分析显示有 87 个有区别的代谢物。对有区别的代谢物的时间进程分析用于选择具有规则和合理变化趋势的更可靠的生物标志物。最终发现并鉴定了 47 个,其中包括 12 个肉碱衍生物、2 个氨基酸衍生物、1 个核苷。基于这些潜在生物标志物的时间进程行为,我们假设这种破坏可能是由于细胞增殖增加、脂肪酸β氧化减少和肾小管重吸收不良引起的。这些研究表明,该方法有助于发现更可靠的潜在生物标志物,并为肿瘤生物系统代谢变化提供有价值的生化见解。